Four Startups Advance to Spring 2023 George Shultz Innovation Fund Finals

Four startups innovating in the life sciences, energy, healthcare IT, and medical device spaces will each vie for up to $250,000 in co-investment as finalists in the Spring 2023 cohort…

Onchilles Pharma Advancing Tumor-Killing Drug Candidate to the Clinic

University of Chicago spinout Onchilles Pharma plans to initiate first-in-human clinical trials next year for its lead drug candidate – which has demonstrated broad, potent, and direct tumor-killing activity. The…

2 Startups Awarded $175,000 Each to Further Develop Cancer Treatment Technologies

Alnair Therapeutics and Riptide Therapeutics have been awarded investments from the George Shultz Innovation Fund to further develop their cancer treatment technologies. Both will receive $175,000 investments from the Fund.…

Riptide Therapeutics Awarded $175,000 From George Shultz Innovation Fund

The George Shultz Innovation Fund (GSIF), managed by the Polsky Center for Entrepreneurship and Innovation, recently selected Riptide Therapeutics, a biopharmaceutical startup led by University of Chicago and Northwestern University…

Alnair Therapeutics Awarded $175,000 From George Shultz Innovation Fund

The George Shultz Innovation Fund (GSIF), managed by the Polsky Center for Entrepreneurship and Innovation, recently selected oncology startup Alnair Therapeutics as a Fall 2022 cohort award winner. The company,…

Cancer’s Achilles’ Heel? UChicago Startup Secures $7 Million to Develop ‘Game-Changer’ Treatments

Onchilles Pharma recently closed its Series A funding round, bringing in approximately $7 million, including a $500,000 investment from the University of Chicago’s Startup Investment Fund. Cofounded by UChicago Associate…

Innovation Fund Invests $575,000 in Biotech Companies

The University of Chicago Innovation Fund announced plans to invest up to $575,000 into three biotechnology companies—ImmunArtes, Onchilles Pharma, and Oxalo Therapeutics. These latest investments bring the Innovation Fund’s total…

This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of products and services, assist with our promotional and marketing efforts.

Accept